mktcap_usd=272877
ConsensRecom=2.27
earning_yield=3.98%
growth=13.62%
dilution=1.43%
div_ratio=62.00%
sh_payout_ratio=26.65%
margin=19.16%
cfmargin=17.75%
ratiopaid=49.80%
sratiopaid=16.80%
ratioConsens=1.06
Description
AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta/Venclyxto; aesthetics products that include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from the AbbVie-owned distribution centers and public warehouses.
Income and Cashflow Statements USD
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-02-17 | 2018-02-16 | 2019-02-27 | 2020-02-21 | 2021-02-19 | 2022-02-18 | 2023-02-17 | NaN | NaN |
| period | 12M | 12M | 12M | 12M | 12M | 12M | 12M | NaN | NaN |
| rev | 25638 | 28216 | 32753 | 33266 | 45804 | 56197 | 58054 | 39990 | 13323 |
| revgrowth | NaN | 9.58% | 14.91% | 1.55% | 31.98% | 20.45% | 3.25% | 13.62% | 11.44% |
| earn | 5953 | 5309 | 5687 | 7882 | 4616 | 11542 | 11836 | 7546 | 3002 |
| earnx | 5953 | 5709 | 5773 | 7882 | 4616 | 11542 | 11836 | 7616 | 2947 |
| margin | 23.22% | 18.82% | 17.36% | 23.69% | 10.08% | 20.54% | 20.39% | 19.16% | 4.59% |
| xmargin | 23.22% | 20.23% | 17.63% | 23.69% | 10.08% | 20.54% | 20.39% | 19.40% | 4.58% |
| earningyld | 5.93% | 3.19% | 4.01% | 6.03% | 2.59% | 4.82% | 4.32% | 4.41% | 1.30% |
| cfop | 7041 | 9960 | 13427 | 13324 | 17588 | 22777 | 24943 | 15580 | 6554 |
| cfinv | -6074 | -274 | -1006 | 596 | -37557 | -2344 | -623 | -6755 | 13756 |
| cffin | -3928 | -5512 | -14396 | 18708 | -11501 | -19039 | -24803 | -8639 | 14087 |
| cfopmargin | 27.46% | 35.30% | 40.99% | 40.05% | 38.40% | 40.53% | 42.97% | 37.96% | 5.21% |
| cfinvmargin | -23.69% | -0.97% | -3.07% | 1.79% | -82.00% | -4.17% | -1.07% | -16.17% | 30.24% |
| cffinmargin | -15.32% | -19.54% | -43.95% | 56.24% | -25.11% | -33.88% | -42.72% | -17.75% | 34.42% |
| shares | 1623 | 1595 | 1539 | 1477 | 1665 | 1768 | 1769 | 1634 | 110 |
| fx | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0 |
| price | 61.9 | 104 | 92.2 | 88.5 | 107 | 135 | 155 | 106 | 30.8 |
| dilution | NaN | -1.73% | -3.62% | -4.09% | 11.99% | 6.03% | 0.06% | 1.44% | 6.33% |
| dividend | 3717 | 4107 | 5580 | 6366 | 7716 | 9261 | 10043 | 6684 | 2441 |
| sharebb | NaN | 2317 | 5578 | 5576 | -18403 | -12552 | -144 | -2938 | 10119 |
| ltdebtbb | NaN | 5487 | -4049 | -27973 | -14579 | 13365 | 5054 | -3782 | 15231 |
| mgtbb | NaN | 6399 | -7287 | 2677 | -36767 | -8965 | -9850 | -8966 | 15154 |
| divyld | 3.70% | 2.46% | 3.93% | 4.87% | 4.33% | 3.87% | 3.67% | 3.83% | 0.74% |
| sharebbyld | NaN | 1.73% | 3.62% | 4.09% | -11.99% | -6.03% | -0.06% | -1.44% | 6.33% |
| mgtyld | NaN | 3.84% | -5.14% | 2.05% | -20.61% | -3.74% | -3.60% | -4.53% | 8.65% |
Balance Sheet
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-02-17 | 2018-02-16 | 2019-02-27 | 2020-02-21 | 2021-02-19 | 2022-02-18 | 2023-02-17 | NaN | NaN |
| mktcap | 100414 | 166647 | 141836 | 130758 | 178395 | 239442 | 273691 | 175883 | 61358 |
| mktcapgrowth | NaN | 50.66% | -16.12% | -8.13% | 31.07% | 29.43% | 13.37% | 16.71% | 25.40% |
| totAsset | 66099 | 70786 | 59352 | 89115 | 150565 | 146529 | 138805 | 103036 | 40695 |
| assetgrowth | NaN | 6.85% | -17.62% | 40.64% | 52.45% | -2.72% | -5.42% | 12.37% | 27.85% |
| curAsset | 16187 | 21223 | 16945 | 49519 | 24173 | 27928 | 28463 | 26348 | 11303 |
| curAssetPct | 24.49% | 29.98% | 28.55% | 55.57% | 16.05% | 19.06% | 20.51% | 27.74% | 13.26% |
| totLiab | 61463 | 65689 | 67798 | 97287 | 137489 | 131121 | 121551 | 97485 | 32916 |
| totLiabPct | 92.99% | 92.80% | 1.14 | 1.09 | 91.32% | 89.48% | 87.57% | 96.79% | 10.46% |
| curLiab | 9781 | 16641 | 17239 | 15585 | 28661 | 35194 | 29538 | 21806 | 9281 |
| curLiabPct | 14.80% | 23.51% | 29.05% | 17.49% | 19.04% | 24.02% | 21.28% | 21.31% | 4.73% |
| ltDebt | 36440 | 30953 | 35002 | 62975 | 77554 | 64189 | 59135 | 52321 | 18010 |
| ltDebtPct | 55.13% | 43.73% | 58.97% | 70.67% | 51.51% | 43.81% | 42.60% | 52.35% | 10.25% |
| Equity | 4636 | 5097 | -8446 | -8172 | 13076 | 15408 | 17254 | 5550 | 10615 |
| EquityPct | 7.01% | 7.20% | -14.23% | -9.17% | 8.68% | 10.52% | 12.43% | 3.21% | 10.46% |
| PB | 21.7 | 32.7 | -16.8 | -16.0 | 13.6 | 15.5 | 15.9 | 9.52 | 18.8 |
Beta
len=128
mean=13.57%
sd=25.03%
alpha=0.39%
beta=62.56%
r_sq=16.03%
lastdate=2023-03-17
firstdate=2013-01-31
logret1y=-4.99%
Financial Snapshot
CompanyName=AbbVie Inc
ID=1
Name=Ordinary Shares
Ticker=ABBV
ISIN=None
RIC=ABBV.K
DisplayRIC=ABBV.N
InstrumentPI=120892222
QuotePI=122128812
InstrumentPermID=21514786348
QuotePermID=21515722707
Exchange=New York Stock Exchange
ExchangeCode=NYSE
ExchangeCountry=USA
CoStatus=Active
CoType=Equity Issue
LastModified=2023-03-14
LatestAvailableAnnual=2022-12-31
LatestAvailableInterim=2022-12-31
Employees=50000
SharesOut=1.769e+09
TotalFloat=1.767e+09
ReportingCurrency=USD
MostRecentExchange=1.0
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
NPRICE=154
NHIG=176
NLOW=134
PDATE=2023-03-17
VOL10DAVG=9.64
EV=326919
MKTCAP=272877
AREV=58054
AEBITD=28870
ANIAC=11781
AEPSXCLXOR=6.63
AREVPS=32.7
ABVPS=9.75
ACSHPS=5.22
ACFSHR=11.5
ADIVSHR=5.64
AGROSMGN=71.5
AROEPCT=72.1
APR2REV=4.70
APEEXCLXOR=23.3
APRICE2BK=15.8
ConsRecom=2.27
TargetPrice=164
ProjLTGrowthRate=-2.50
ProjPE=13.9
ProjSales=52547
ProjSalesQ=12133
ProjEPS=11.1
ProjEPSQ=2.56
ProjProfit=22817
ProjDPS=5.95
quoteccy=USD
quotefx=100.00%
exchgccy=USD
exchgfx=100.00%
tick=None
exchg=None
Valuation
ticker=ABBV
exchg=AMEX
RIC=ABBV.K
CompanyName=AbbVie Inc
ExchangeCode=NYSE
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
sector=56 Healthcare
region=us
ccy=USD
fx=100.00%
mktcap_usd=272877
float_usd=272432
ConsensRecom=2.27
earning_yield=3.98%
growth=13.62%
dilution=1.43%
margin=19.16%
searning_yield=3.09%
sgrowth=3.19%
smargin=14.91%
sdilution=7.21%
projearning_yield=6.93%
earning_excl_yield=4.21%
div_ratio=62.00%
bb_ratio=-35.35%
sh_payout_ratio=26.65%
PS=4.72
price=154
ratio=51.20%
sratio=17.15%
sratiopaid=16.80%
ratioConsens=1.06
turnover=40.25%
cfmargin=17.75%
rdmargin=14.86%
scfmargin=-14.11%
quoteccy=USD
quotefx=100.00%
ratiopaid=49.80%
dt=2023-03-17
assetgrowth=12.35%
dlnfx=0